Professor Dr Detlev Ganten
- Section Global Health
- Location Berlin, Germany
- Election year 1993
Research
Detlev Ganten studied medicine at the universities of Würzburg, Montpellier (France) and Tübingen. He spent several years as a research scientist at the Clinical Research Institute in Montreal (Canada), and earned his Ph.D. at McGill University. In 1975 Detlev Ganten was appointed Professor at the Department of Pharmacology at the University of Heidelberg. From 1991 to 2004 Detlev Ganten was the founding director and president of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. From 2004 to 2008 Detlev Ganten was Chief Executive Officer at the Charité – Universitätsmedizin Berlin. Since 2005 is Detlev Ganten the Chairman of the Board of the Charité Foundation. His area of research includes molecular genetics of cardiovascular diseases.
Hauptarbeitsgebiete: Bluthochdruckforschung, besonders Renin-Angiotensin-System, extrarenale Lokalisation des Renins, Nachweis der Freisetzung des Renins aus dem Gefäßgebiet des Splanchnikus, Renin-Aktivitäten in Gehirn, Herz und Nebenniere; Anwendung transgenischer Technologien in der Hochdruckforschung, Erzeugung genetisch hypersensitiver Rattenstämme
Hauptarbeitsgebiete: Bluthochdruckforschung, besonders Renin-Angiotensin-System, extrarenale Lokalisation des Renins, Nachweis der Freisetzung des Renins aus dem Gefäßgebiet des Splanchnikus, Renin-Aktivitäten in Gehirn, Herz und Nebenniere; Anwendung transgenischer Technologien in der Hochdruckforschung, Erzeugung genetisch hypersensitiver Rattenstämme
Career
- 2010 Guest Professorship, Collège de France, Paris, France
- since 2009 President World Health Summit; Chairman of Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology, Germany
- since 2005 Chairman of the Board, Charité Foundation, Germany
- 2004-2008 Chief Executive Officer, Charité Berlin, Germany
- 1991-2004 Founding Director, Max Delbrück Center for Molecular Medicine (MDC) Berlin‐Buch, Germany
- 1975 Professor of Pharmacology, University of Heidelberg, Germany
- 1973 Ph.D., McGill University, Montreal, Canada
- 1969-1973 Research Fellow, Clinical Research Institute, Université de Montreal, Canada
- 1968 M.D. degree, University of Tübingen, Germany
- 1962-1968 Medical Studies at the Universities of Würzburg, Montpellier, Tübingen, Germany
Functions
- since 2013 Co-Chair, Interacademy Medical Panel (IAMP)
- 2002-2007 German National Ethics Council
- 1997-2001 President of the Helmholtz‐Association of National Research Centers
- 1996-1998 President of the Society of German Scientists and Medicines (GDNÄ)
- 1993-1998 Science Council, German Federal Government
- 1992-1997 Health Research Council, German Federal Ministry of Education and Research
- 1990-1995 President of the World Hypertension League
Projects
- since 2011 Board of Trustees, University Paris Sciences Lettres PSL
- since 2011 Scientific Advisory Board, University Sorbonne Paris Cité
- since 2009 President of the World Health Summit; Chairman of Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology, Potsdam, Germany
- since 2009 Scientific Advisory Board, Agence Nationale der Recherche (ANR), Paris, France
- since 2005 Chairman of the Board, Charité Foundation, Germany
- 1962-1968 Medical Studies at the Universities of Würzburg, Montpellier, Tübingen, Germany
Honours and Memberships
- 2017 Honorary doctorate, University of Coimbra, Portugal
- 2016 Honorary doctorate, Charité, Berlin
- 2003 Légion d’honneur, France
- 2002 Honorary Professorship, Wuhan University, China
- 2000 Federal Cross of Merit, Germany
- 1995 Dr. honoris causa University Iasi, Rumania
- 1992 CIBA Award of the Council for High Blood Pressure Research, American Heart Association
- 1990 Max Planck Research Award; Okamoto Award, Japan
- 1981 Science Award of the German League for Combating High Blood Pressure; Sechenev Medal of the Medical Academy Moscow; Chavez Award of the International Society of Hypertension